Innovation to Implementation Supplement (I2IS), – NOI/LOI

Well-being, Health and Biomedical Discovery


Academic Unit: Inquire within your unit

Memorial Deadline: No RGCS review required for the LOI/NOI

External Deadline: Wednesday 26th, January 2022


The Ontario Institute for Cancer Research (OICR) is inviting applications for the Innovation to Implementation Supplement (I2IS), which is focused on overcoming barriers to the mobilization, or uptake, of knowledge required to inform adoption of OICR research assets into policy or health care. OICR is committed to providing research funding to help support a sustainable health system that enables fair and equitable access to cancer interventions. I2IS is a supplement for OICR research projects supported within the last five years to move them from an experimental phase towards clinical use.

I2IS funding has two main purposes:

  • To support research projects needed to overcome implementation bottlenecks and provide optimal approaches to accelerate the uptake and sustainability of OICR-supported research outputs in population health, cancer screening and clinical settings; and
  • To support efforts to synthesize, disseminate, exchange and apply knowledge related to OICR-funded research in order to build on and use that knowledge to improve high-quality decision making to support health, the healthcare system or healthcare delivery.


I2IS is a supplement for projects that have received OICR support between April 1, 2016 and November 30, 2021 (the ‘eligibility term’). To be eligible, the applicant must have been listed as a Principal Investigator (PI), co-PI, Investigator, or co-Investigator on a previously supported OICR project within the eligibility term. Applications from Investigators who have not received OICR funding over the eligibility term will only be accepted if a co-PI, who has received OICR support for the related project over the eligibility term, is also listed on the application. Applicants are eligible to submit a single I2IS application as the PI or Co-PI. PI/Co-PIs may participate on separate I2IS applications as Co-Investigators or Collaborators.

Funding available

Up to $100,000 per year, inclusive of overhead, for a maximum of one year. The annual budget for the entire I2IS funding stream is $600,000. OICR funding is only tenable in Ontario and can only be disbursed to not-for-profit entities.

Deadlines and important dates: 

RFA information session: January 12, 2022, 10-11 a.m. ET
(register here to attend)
Notice of Intent (NOI) deadline: No later than January 26 by 5 p.m. ET
Letter of Intent (LOI) deadline: January 26, 2022 by 5 p.m. ET
LOI results communicated: Week of March 7, 2022
Full application deadline: April 28, 2022 by 5 p.m. ET
Notification of results: End of June 2022
Funding to begin: July 1, 2022

Full Details, please visit


Funding Sources

Ontario Institute for Cancer Research

This opportunity was posted by: RGCS

Last modified: December 9, 2021